Richmond-Prohaska v. Ethicon Inc et al, No. 2:2023cv00210 - Document 24 (W.D. Wash. 2023)
Court Description: ORDER granting in part and denying in part Defendant's 20 Motion to Dismiss Second Amended Complaint. The court GRANTS Ethicon's motion to dismiss Ms. Richmond-Prohaska's manufacturing defect claim and DISMISSES that claim with leave to amend. Ms. Richmond-Prohaska may file a third amended complaint that addresses the deficiencies identified in this order by no later than 9/15/2023. The court DENIES Ethicon's motion to dismiss Ms. Richmond-Prohaska's design defect and failure to warn claims. Signed by Judge James L. Robart. (SB)
Download PDF
<![CDATA[
Richmond-Prohaska v. Ethicon Inc et al Doc. 24 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 1 of 11 1 2 3 4 5 6 7 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE 8 9 DEBRA RICHMOND-PROHASKA, 10 ORDER Plaintiff, 11 CASE NO. C23-0210JLR v. 12 ETHICON, INC., 13 Defendant. 14 15 I. 16 INTRODUCTION Before the court is Defendant Ethicon, Inc.’s (“Ethicon”) motion to dismiss 17 Plaintiff Debra Richmond-Prohaska’s second amended complaint. (Mot. (Dkt. # 20); 18 Reply (Dkt. # 23); see 2d Am. Compl. (Dkt. # 17).) Ms. Richmond-Prohaska opposes 19 Ethicon’s motion to dismiss. (Resp. (Dkt. # 22).) The court has considered the motion, 20 the parties’ submissions, the relevant portions of the record, and the governing law. 21 // 22 // ORDER - 1 Dockets.Justia.com Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 2 of 11 1 Being fully advised, 1 the court GRANTS in part and DENIES in part Ethicon’s motion to 2 dismiss. 3 II. BACKGROUND 4 On May 4, 2010, Ms. Richmond-Prohaska “underwent a transvaginal tape sling 5 with cystoscopy, anterior repair, and posterior repair with Elevate Apical and Posterior 6 System with IntePro Lite mesh.” (2d Am. Compl. ¶ 2.) During this procedure, which 7 took place “relative to her pre-operative diagnosis for stress incontinent [sic] and vaginal 8 prolapse,” Ms. Richmond-Prohaska was implanted with Ethicon’s “Gynecare TVT 9 transvaginal mesh, product number 810041B, Lot. No. 3389734.” 2 (Id. ¶¶ 3-4.) On the 10 same date, another mesh was also implanted that was manufactured by a non-party to this 11 case. (Id. ¶ 5.) By May 2020, Ms. Richmond-Prohaska was experiencing discomfort and 12 “underwent a pelvic examination that revealed a less than 1cm [sic] ring of vaginal sling 13 mesh extrusion from the pelvic region.” (Id. ¶ 6.) On May 27, 2020, Ms. Richmond- 14 Prohaska underwent revision surgery, “which involved revision of the mesh and 15 cystoscopy; and trimmed the extrusion.” (Id. ¶ 7.) She alleges that “as a direct and 16 proximate cause of having [Ethicon’s] Gynemesh implanted, [she has] suffered extensive 17 18 19 20 21 22 1 Neither party has requested oral argument (see Mot. at 1; Resp. at 1) and the court finds that oral argument would not be helpful to its resolution of the motion, see Local Rules W.D. Wash. LCR 7(b)(4). 2 The parties refer to this product as “Gynecare TVT,” “TVT,” “Gynemesh,” and “the Pelvic Mesh Product.” (See, e.g., 2d Am. Compl. ¶ 11 (stating that it refers to Gynecare TVT as the “Pelvic Mesh Product”); id. ¶ 102 (referring to “Defendant’s Pelvic Mesh Product, Gynemesh”); see generally Mot. (referring to Ethicon’s product as “TVT”).) For consistency, the court refers to the product as “Gynecare TVT” except when quoting Ms. RichmondProhaska’s second amended complaint. ORDER - 2 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 3 of 11 1 physical injury and has accrued economic loss, including but not limited to obligations 2 for medical care.” (Id. ¶ 8.) Specifically, Ms. Richmond-Prohaska alleges that she has 3 experienced “dyspareunia, extrusion, inability to engage in sexual relations, and pain or 4 general discomfort” after being implanted with Gynecare TVT. (Id. ¶¶ 55-56.) 5 Ms. Richmond-Prohaska alleges that Ethicon knew that there were multiple 6 defects in the design and manufacture of Gynecare TVT—for example, that its product 7 contains harmful materials—and knew that these defects led to injuries in many women 8 in whom the mesh was implanted. (See generally id. ¶¶ 17-100.) Nevertheless, 9 according to Ms. Richmond-Prohaska, Ethicon aggressively marketed Gynecare TVT and 10 insisted that it was safe and effective for treatment of incontinence and prolapse. (Id.) 11 Ms. Richmond-Prohaska further alleges that Ethicon misrepresented the safety of 12 Gynecare TVT and failed to provide adequate warnings of its defects, risks, and dangers. 13 (Id.) 14 Ms. Richmond-Prohaska filed the instant action on February 16, 2023. (Compl. 15 (Dkt. # 1).) She amended her complaint on April 18, 2023. (Am. Compl. (Dkt. # 7).) 16 On June 15, 2023, Ethicon and former Defendant Ethicon, LLC (together, “Defendants”) 17 moved to dismiss the amended complaint. (1st MTD (Dkt. # 13).) On June 29, 2023, the 18 parties stipulated to strike Defendants’ first motion to dismiss; to dismiss Ethicon, LLC 19 from this action; and to allow Ms. Richmond-Prohaska to file a second amended 20 complaint. (See Dkt. ## 15-16 (stipulated motions); Dkt. ## 18-19 (orders granting 21 stipulated motions).) 22 ORDER - 3 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 4 of 11 1 Ms. Richmond-Prohaska filed her second amended complaint on June 29, 2023. 2 (2d Am. Compl.) She alleges design defect, manufacturing defect, and failure to warn 3 claims under Washington’s Product Liability Act (“WPLA”), ch. 7.72 RCW. (Id. 4 ¶¶ 101-37.) Ethicon filed this motion to dismiss Ms. Richmond-Prohaska’s second 5 amended complaint on July 19, 2023. (Mot.) 6 III. 7 The court sets forth the standard of review before turning to Ethicon’s motion to 8 dismiss. 9 A. 10 ANALYSIS Standard of Review Federal Rule of Civil Procedure 12(b)(6) provides for dismissal when a complaint 11 “fail[s] to state a claim upon which relief can be granted.” Fed. R. Civ. P. 12(b)(6). 12 Under this standard, the court construes the allegations in the light most favorable to the 13 nonmoving party, Livid Holdings Ltd. v. Salomon Smith Barney, Inc., 416 F.3d 940, 946 14 (9th Cir. 2005), and asks whether the claim contains “sufficient factual matter, accepted 15 as true, to ‘state a claim to relief that is plausible on its face,’” Ashcroft v. Iqbal, 556 U.S. 16 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). The 17 court need not accept as true legal conclusions, “formulaic recitation[s] of the legal 18 elements of a cause of action,” Chavez v. United States, 683 F.3d 1102, 1008 (9th Cir. 19 2012), or “allegations that are merely conclusory, unwarranted deductions of fact, or 20 unreasonable inferences,” Sprewell v. Golden State Warriors, 266 F.3d 979, 988 (9th Cir. 21 2001). “A claim has facial plausibility when the plaintiff pleads factual content that 22 ORDER - 4 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 5 of 11 1 allows the court to draw the reasonable inference that the defendant is liable for the 2 misconduct alleged.” Iqbal, 556 U.S. at 678. 3 B. 4 Motion to Dismiss The WPLA is the exclusive remedy for product liability claims in Washington and 5 “creates a single cause of action for product-related harm with specified statutory 6 requirements for proof.” Kirkland v. Emhart Glass S.A., 805 F. Supp. 2d 1072, 1076 7 (W.D. Wash. 2011) (first citing Washington Water Power Co. v. Graybar Elec. Co., 774 8 P.2d 1199, 1203 (Wash. 1989); and then citing Wash. State Physicians Ins. Exch. & Ass’n 9 v. Fisons Corp., 858 P.2d 1054, 1066 (Wash. 1993)). The WPLA distinguishes between 10 and imposes different standards of liability on product manufacturers and product sellers 11 for harm caused by defective products. See RCW 7.72.030-.040. Under the WPLA, a 12 manufacturer is subject to liability “if the claimant’s harm was proximately caused by the 13 negligence of the manufacturer in that the product was not reasonably safe as designed or 14 not reasonably safe because adequate warnings or instructions were not provided.” RCW 15 7.72.030(1). A manufacturer is also subject to liability “if the claimant’s harm was 16 proximately caused by the fact that the product . . . deviated in some material way from 17 the design specifications or performance standards of the manufacturer, or deviated in 18 some material way from otherwise identical units of the same product line.” RCW 19 7.72.030(2)(a). 20 Ethicon argues that the court must dismiss (1) all of Ms. Richmond-Prohaska’s 21 WPLA claims because she has not plausibly alleged the causation element of those 22 claims and (2) Ms. Richmond-Prohaska’s manufacturing defect claim because she has not ORDER - 5 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 6 of 11 1 alleged that the Gynecare TVT that caused her injuries deviated in some way from its 2 design specification. (Mot. at 4-7.) The court considers each argument in turn. 3 1. Causation 4 Ethicon moves the court to dismiss all three of Ms. Richmond-Prohaska’s claims 5 because she “has not alleged with any detail how [Ethicon’s] conduct caused her 6 nondescript injuries.” (Mot. at 4.) Specifically, according to Ethicon, Ms. Richmond- 7 Prohaska “does not even specify what injuries she claims to be attributable to her 8 [Gynecare] TVT (as opposed to the other mesh device), much less link her injuries with 9 any ‘defect’ in the product or its warnings.” (Id.; see also id. at 4-5 (“And although she 10 alleges she underwent a ‘revision of the mesh,’ she does not even specify which of her 11 two mesh devices.” (quoting 2d Am. Compl. ¶ 7) (emphasis in original)); Reply at 2 12 (arguing that Ms. Richmond-Prohaska “merely alleges that [she] experienced 13 complications from ‘mesh’ that was implanted in her without alleging which mesh”) 14 (emphasis in original).) 15 The court is not persuaded. The second amended complaint contains over 100 16 paragraphs of allegations discussing Gynecare TVT, and Ms. Richmond-Prohaska 17 expressly alleges that she suffered injuries “as a direct and proximate result of having 18 Defendant Ethicon’s Gynemesh implanted.” (2d Am. Compl. ¶ 8; see also id. ¶¶ 55-56 19 (listing types of injuries suffered by women who have been implanted with Gynecare 20 TVT and alleging that Ms. Richmond-Prohaska has experienced several of them). The 21 court concludes that Ms. Richmond-Prohaska has pleaded sufficient factual content to 22 support the reasonable inference that she is referring to Ethicon’s Gynecare TVT in her ORDER - 6 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 7 of 11 1 allegations regarding injuries caused by “the mesh.” See Iqbal, 556 U.S. at 678. 2 Ethicon’s motion to dismiss based on causation is, therefore, denied. 3 2. Manufacturing Defect 4 Second, Ethicon contends that the court must dismiss Ms. Richmond-Prohaska’s 5 manufacturing defect claim because she “fails to identify any deviation of her TVT mesh 6 from Ethicon’s design specification.” (Mot. at 5-7.) 7 Under the WPLA, a manufacturing defect claim requires a showing “that the 8 product deviated in some material way from the design specifications of the manufacturer 9 or deviated in some material way from otherwise identical units of the same product 10 line.” Hernandez v. Johnson & Johnson, No. 4:20-CV-05136-SMJ, 2021 WL 320612, at 11 *4 (E.D. Wash. Jan. 8, 2021) (citing RCW 7.72.030). “Whereas design defects and 12 warning defects apply to the entire product line, a manufacturing defect is found where 13 the particular product that injured the plaintiff contained a ‘flaw,’ departing from the 14 specifications for the product line as a whole.” 16A Wash. Prac., Tort Law and Practice 15 § 17.11 (5th ed.) (citing Bylsma v. Burger King Corp., 293 P.3d 1168 (Wash. 2013)). 16 Ethicon relies primarily on Harju v. Johnson & Johnson, No. C20-6258BHS-JRC, 17 2021 WL 3929232 (W.D. Wash. Sept. 2, 2021), in which the court dismissed a similar 18 pelvic mesh manufacturing defect claim. In that case, the plaintiffs alleged that 19 “Defendants’ manufacturing of the [pelvic mesh products] were [sic] defective due to the 20 use of non-medical grade material and inadequate specifications that were not adhered to 21 in the manufacturing of Plaintiffs’ [pelvic mesh products].” 2d Am. Compl. ¶ 128, Harju 22 ORDER - 7 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 8 of 11 1 v. Johnson & Johnson, No. C20-6258BHS-JRC (W.D. Wash. Apr. 15, 2021), Dkt. # 29. 3 2 The court ruled that the plaintiffs had failed to plead a plausible manufacturing defect 3 claim because they did not allege how the pelvic mesh products that were implanted in 4 them deviated from their intended design. Harju, 2021 WL 3929232, at *2. Instead, 5 according to the court, the plaintiffs had alleged that the “products in general were 6 defective due to, among others, the use of non-medical grade material.” Id. (emphasis in 7 original); see also id. (“Plaintiffs’ allegations do not support an inference that their 8 specific products departed from proper specifications; rather, Plaintiffs allege that every 9 mesh product was defective.”). Thus, the court concluded that Plaintiffs’ allegations 10 “sound[ed] in a design defect, not in a manufacturing defect” and dismissed the 11 manufacturing defect claim. Id. 12 Here, Ms. Richmond-Prohaska alleges that Ethicon’s “manufacturing of 13 Gynemesh was defective due to the use of non-medical grade material and inadequate 14 specifications that were not adhered to in the manufacturing of [Ms. Richmond- 15 Prohaska’s] Gynemesh”—an allegation almost identical to the one made by the Harju 16 plaintiffs. (2d Am. Compl. ¶ 113.) She also alleges that the “use of non-medical grade 17 polypropylene in [Ethicon’s] manufacturing process for Gynemesh resulted in an 18 19 20 21 22 3 Although review of a motion to dismiss is generally limited to the contents of the complaint, courts may “consider certain materials—documents attached to the complaint, documents incorporated by reference in the complaint, or matters of judicial notice—without converting the motion to dismiss into a motion for summary judgment.” United States v. Ritchie, 342 F.3d 903, 908 (9th Cir. 2003). Because the Harju second amended complaint is a matter of judicial notice, the court grants Ethicon’s unopposed request to consider it in deciding this motion. (See Mot. at 5-6; Resp.) ORDER - 8 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 9 of 11 1 unwanted, elongation, migration and creeping reaction in Plaintiff” and that “[t]he 2 Gynemesh implanted in Plaintiff deviated by its intended designs by utilizing a propylene 3 mesh that degrades, contracts, shrinks, migrates . . . [and] otherwise deforms and 4 disintegrates inside the body.” (2d Am. Compl. ¶¶ 114-15.) These allegations, like those 5 of the Harju plaintiffs, relate to the properties of Gynecare TVT in general, rather than to 6 deviations from Gynecare TVT’s design that occurred in the specific units of Gynecare 7 TVT that were implanted in Ms. Richmond-Prohaska. The court concludes that Ms. 8 Richmond-Prohaska’s allegations, like those at issue in Harju, “sound in a design defect, 9 not in a manufacturing defect,” and thus fail to plausibly allege a manufacturing defect 10 11 claim. Harju, 2021 WL 3929232, at *2. Ms. Richmond-Prohaska protests that, unlike the plaintiffs in Harju, she “is 12 alleging that a manufacturing defect exists due to the defective nature of Gynemesh 13 products as a whole.” (Resp. at 8.) She asserts that “[n]o manufacturer of such devices 14 should have knowingly designed, manufactured, or sold a product they knew would 15 extrude, elongate, creep, bend, fray or act in any other manner alleged in” her second 16 amended complaint. (Id.) The WPLA, however, requires Ms. Richmond-Prohaska to 17 plausibly allege that the product that caused her specific harm deviated in some way from 18 its design specification, its standards, or otherwise identical units of the same product. 19 RCW 7.72.080(2)(a). Ms. Richmond-Prohaska has not done so. (See generally 2d Am. 20 Compl.) Accordingly, the court GRANTS Ethicon’s motion to dismiss Ms. Richmond- 21 Prohaska’s manufacturing defect claim. 22 ORDER - 9 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 10 of 11 1 3. Leave to Amend 2 On a Rule 12(b)(6) motion, “a district court should grant leave to amend even if no 3 request to amend the pleading was made, unless it determines that the pleading could not 4 possibly be cured by the allegation of other facts.” Cook, Perkiss & Liehe v. N. Cal. 5 Collection Serv., 911 F.2d 242, 247 (9th Cir. 1990). Although Ms. Richmond-Prohaska 6 has already amended her complaint twice, the court is not convinced that further 7 amendment would be futile. See Harju, 2021 WL 3929232, at *3 (allowing plaintiffs 8 leave to amend their dismissed manufacturing defect claim because it was still possible 9 that they could obtain facts to support such a claim during discovery). Accordingly, the 10 court GRANTS Ms. Richmond-Prohaska leave to file a third amended complaint that 11 addresses the deficiencies identified in this order. 12 IV. 13 CONCLUSION For the foregoing reasons, the court GRANTS in part and DENIES in part 14 Ethicon’s motion to dismiss (Dkt. # 20). The court GRANTS Ethicon’s motion to 15 dismiss Ms. Richmond-Prohaska’s manufacturing defect claim and DISMISSES that 16 claim with leave to amend. Ms. Richmond-Prohaska may file a third amended complaint 17 that addresses the deficiencies identified in this order by no later than September 15, 18 // 19 // 20 // 21 // 22 // ORDER - 10 Case 2:23-cv-00210-JLR Document 24 Filed 08/28/23 Page 11 of 11 1 2023. The court DENIES Ethicon’s motion to dismiss Ms. Richmond-Prohaska’s design 2 defect and failure to warn claims. 3 Dated this 28th day of August, 2023. A 4 5 JAMES L. ROBART United States District Judge 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ORDER - 11
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
